nach oben

Erschienen in:

21.02.2018 | Review articles

Palliative care in heart failure

A meta-analysis of randomized controlled trials

verfasst von: K. Zhou, Y. Mao

Erschienen in: Herz | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Palliative care can play an important role in the management of heart failure. We conducted a systematic review and meta-analysis to compare the efficacy and safety of palliative care in patients with heart failure.

Methods

PubMed, Embase, Web of Science, EBSCO, and the Cochrane Library databases were systematically searched. Randomized controlled trials (RCTs) on the impact of palliative care on heart failure were included. Two investigators independently searched the articles, extracted data, and assessed the quality of included studies. The primary outcome was mortality.

Results

Seven RCTs were included in the meta-analysis. Compared with usual care for heart failure, palliative care was associated with a significantly increased quality of life (standardized mean difference = 1.46; 95% confidence interval [CI] = 0.12 to 2.79; p = 0.03) and reduced depression scores (standardized mean difference = −0.62; 95% CI = −0.99 to −0.25; p = 0.03), but demonstrated no impact on mortality (risk ratio [RR] = 1.28; 95% CI = 0.86 to 1.92; p = 0.22) and rehospitalization (RR = 0.84; 95% CI = 0.66 to 1.07; p = 0.16).

Conclusion

Palliative care can improve the quality of life and reduce the occurrence of depression in patients with heart failure.

Yancy CW, Jessup M, Bozkurt B et al (2016) 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol 68:1476–1488CrossRefPubMed

Packer M, Pitt B, Rouleau JL et al (2017) Long-term effects of flosequinan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the PROFILE trial after 24 years. JACC Heart Fail 5:399–407CrossRefPubMed

Joyce E, Lala A, Stevens SR et al (2016) Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations. JACC Heart Fail 4:923–931CrossRefPubMedPubMedCentral

Go AS, Mozaffarian D, Roger VL et al (2013) Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127:143–152CrossRefPubMed

Shah SJ, Kitzman DW, Borlaug BA et al (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134:73–90CrossRefPubMedPubMedCentral

Jaarsma T, Johansson P, Agren S, Stromberg A (2010) Quality of life and symptoms of depression in advanced heart failure patients and their partners. Curr Opin Support Palliat Care 4:233–237CrossRefPubMed

Bekelman DB, Havranek EP, Becker DM et al (2007) Symptoms, depression, and quality of life in patients with heart failure. J Card Fail 13:643–648CrossRefPubMed

Huang WL, Yang Y, Yang J et al (2017) Use of tolvaptan vs. furosemide in older patients with heart failure : meta-analysis of randomized controlled trials. Herz. https://doi.org/10.1007/s00059-017-4563-4 CrossRefPubMed

Arnold B (2010) ACP Journal Club. Early palliative care improved quality of life in patients with newly diagnosed metastatic NSCLC. Ann Intern Med 153:JC6–JC3

10.

Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed

11.

Wilson KG, Dalgleish TL, Chochinov HM et al (2016) Mental disorders and the desire for death in patients receiving palliative care for cancer. BMJ Support Palliat Care 6:170–177CrossRefPubMed

12.

Goodlin SJ (2009) Palliative care in congestive heart failure. J Am Coll Cardiol 54:386–396CrossRefPubMed

13.

Morrison RS, Dietrich J, Ladwig S et al (2011) Palliative care consultation teams cut hospital costs for medicaid beneficiaries. Health Aff 30:454–463CrossRef

14.

Kelley AS, Meier DE (2010) Palliative care—a shifting paradigm. N Engl J Med 363:781–782CrossRefPubMed

15.

DeSanto-Madeya S, McDermott D, Zerillo JA et al (2017) Developing a model for embedded palliative care in a cancer clinic. BMJ Support Palliat Care 7:247–250PubMed

16.

Enguidanos S, Portanova J (2014) The provision of home-based palliative care for those with advanced heart failure. Curr Opin Support Palliat Care 8(1):4–8CrossRefPubMed

17.

Brumley RD, Enguidanos S, Cherin DA (2003) Effectiveness of a home-based palliative care program for end-of-life. J Palliat Med 6:715–724CrossRefPubMed

18.

Bakitas M, Lyons KD, Hegel MT et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302:741–749CrossRefPubMedPubMedCentral

19.

Nieder C, Norum J (2012) Early palliative care in patients with metastatic non-small cell lung cancer. Ann Palliat Med 1:84–86PubMed

20.

Greer JA, Pirl WF, Jackson VA et al (2012) Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 30:394–400CrossRefPubMed

21.

Sidebottom AC, Jorgenson A, Richards H et al (2015) Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial. J Palliat Med 18:134–142CrossRefPubMed

22.

Evangelista LS, Lombardo D, Malik S et al (2012) Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure. J Card Fail 18:894–899CrossRefPubMedPubMedCentral

23.

Rogers JG, Patel CB, Mentz RJ et al (2017) Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial. J Am Coll Cardiol 70:331–341CrossRefPubMedPubMedCentral

24.

Brannstrom M, Boman K (2014) Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study. Eur J Heart Fail 16:1142–1151CrossRefPubMed

25.

Moher D, Liberati A, Tetzlaff J, Altman DG et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentral

26.

Higgins JPTGS (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration (Available from www.cochrane-handbook.org.)

27.

Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRefPubMed

28.

Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135:982–989CrossRefPubMed

29.

Wong FK, Ng AY, Lee PH et al (2016) Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial. Heart 102:1100–1108CrossRefPubMed

30.

Hopp FP, Zalenski RJ, Waselewsky D et al (2016) Results of a hospital-based palliative care intervention for patients with an acute exacerbation of chronic heart failure. J Card Fail 22:1033–1036CrossRefPubMed

31.

Sahlen KG, Boman K, Brannstrom M (2016) A cost-effectiveness study of person-centered integrated heart failure and palliative home care: based on a randomized controlled trial. Palliat Med 30:296–302CrossRefPubMed

32.

Nwosu AC, Collins B, Mason S (2017) Big data analysis to improve care for people living with serious illness: the potential to use new emerging technology in palliative care. Palliat Med 32(1):164. https://doi.org/10.1177/0269216317726250 CrossRefPubMedPubMedCentral

33.

Horton JR, Morrison RS, Capezuti E et al (2016) Impact of inpatient palliative care on treatment intensity for patients with serious illness. J Palliat Med 19:936–942CrossRefPubMedPubMedCentral

34.

Bekelman DB, Rabin BA, Nowels CT et al (2016) Barriers and facilitators to scaling up outpatient palliative care. J Palliat Med 19:456–459CrossRefPubMed

35.

Kelkar AA, Spertus J, Pang P et al (2016) Utility of patient-reported outcome instruments in heart failure. JACC Heart Fail 4:165–175CrossRefPubMed

36.

Allen LA, Stevenson LW, Grady KL et al (2012) Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation 125:1928–1952CrossRefPubMedPubMedCentral

37.

Lum HD, Carey EP, Fairclough D et al (2016) Burdensome physical and depressive symptoms predict heart failure-specific health status over one year. J Pain Symptom Manage 51:963–970CrossRefPubMedPubMedCentral

38.

Stuart B (2007) The nature of heart failure as a challenge to the integration of palliative care services. Curr Opin Support Palliat Care 1(4):249. https://doi.org/10.1097/SPC.0b013e3282f283b6 CrossRefPubMed

39.

Kavalieratos D, Mitchell EM, Carey TS et al (2014) “Not the ‘grim reaper service’”: an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure. J Am Heart Assoc. https://doi.org/10.1161/JAHA.113.000544 CrossRefPubMedPubMedCentral

40.

Gadoud A, Jenkins SM, Hogg KJ (2013) Palliative care for people with heart failure: summary of current evidence and future direction. Palliat Med 27:822–828CrossRefPubMed

41.

Wong FKY, So C, Ng AYM et al (2017) Cost-effectiveness of a transitional home-based palliative care program for patients with end-stage heart failure. Palliat Med. https://doi.org/10.1177/0269216317706450 CrossRefPubMed

42.

Lukas L, Foltz C, Paxton H (2013) Hospital outcomes for a home-based palliative medicine consulting service. J Palliat Med 16:179–184CrossRefPubMed

43.

Wong FK, Chau J, So C et al (2012) Cost-effectiveness of a health-social partnership transitional program for post-discharge medical patients. BMC Health Serv Res 12:479CrossRefPubMedPubMedCentral

Titel: Palliative care in heart failure
A meta-analysis of randomized controlled trials
verfasst von: K. Zhou
Y. Mao
Publikationsdatum: 21.02.2018
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 5/2019
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-017-4677-8

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

CME: Kardiale Speichererkrankungen – Stellenwert der genetischen Diagnostik

The right atrium in idiopathic hypereosinophilic syndrome

Intracardiac echocardiography for percutaneous patent foramen ovale and atrial septal defect occlusion

Direct transfer of STEMI patients to cardiac catheterization laboratory